Pfizer Inc (MIL:1PFE)
€ 25 -0.395 (-1.56%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 63/100

Pfizer Inc at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript

Jan 06, 2022 / 03:00PM GMT
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everybody. Hello, and welcome. Happy new year to 2022. My name is Chris Shibutani. I'm a member of the Goldman Sachs healthcare team. Thank you so much for joining us for this 14th edition of CEOs Unscripted.

We are very pleased to have Pfizer join us this morning. Dr. Albert Bourla, CEO. Albert, thank you so much for joining us.

Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO

Hi there. Thank you very much, Chris, for having me. Happy new year to you and to everyone.

Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Excellent. We'd like to begin the presentation with the forward-looking statements commentary from the Chief of Investor Relations and Senior Vice President, Chris Stevo. Chris, please go ahead.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thanks, Chris. Happy new year. So we're going to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot